The basic principles of immunosuppressive therapy after kidney transplantation

The article deals with medical and organizational issues of individually-adapted immunosuppressive therapy in renal allograft recipients. In the recent years, the basis of nephroprotective therapy schemes includes m-TOR inhibitors. The accessibility of these drugs for those in need is limited. Meanw...

Full description

Bibliographic Details
Main Author: D. N. Suslov
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-03-01
Series:Трансплантология (Москва)
Subjects:
Online Access:https://www.jtransplantologiya.ru/jour/article/view/215
Description
Summary:The article deals with medical and organizational issues of individually-adapted immunosuppressive therapy in renal allograft recipients. In the recent years, the basis of nephroprotective therapy schemes includes m-TOR inhibitors. The accessibility of these drugs for those in need is limited. Meanwhile, a more widespread use of these drugs in clinical transplantation would both increase the life span of a transplanted kidney, and reduce the risk of viral infections and cancer in the long-term after kidney transplantation, and would also allow a rational use of budget funds for the treatment of such patients.
ISSN:2074-0506
2542-0909